Anthrax Vaccine

This page contains recent news articles, when available, and an overview of Anthrax Vaccine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Anthrax Vaccine

Vaccine maker expanding in city  -  ‎Nov 14, 2009‎
Baltimore SunA Maryland maker of anthrax vaccine said Friday that it has bought a 55000-square-foot manufacturing plant in East Baltimore that it will use to expand its ...

Business news briefs  -  ‎Nov 21, 2009‎
Lansing State JournalEmergent BioSolutions Inc. has taken another step toward expanding production of its anthrax vaccine in Lansing. The Rockville, Md.-based company said it ...

Half a dozen of one...  -  ‎Nov 20, 2009‎
OmniNerd (blog)Please be advised that the “uproar� was not about squalene in individually tested Anthrax Vaccine samples. It was about “Antibodies to Squalene in ...

CONFER: Concerns for H1N1 vaccine  -  ‎Nov 16, 2009‎
Tonawanda NewsSqualene was added to the anthrax vaccine for the sake of convenience. It allowed the United States military to quickly and, in their eyes, effectively, ...

NIAID to fund development of Emergent BioSolutions' vaccine candidate  -  ‎Nov 5, 2009‎“We are excited about receiving NIAID funding support for dmPA7909, one of Emergent's next generation anthrax vaccine candidates in development,� said W. ...

Blackout: Military Personnel Banned From H1N1 Vaccine Sites  -  ‎Nov 5, 2009‎
Huffington Post (blog)I started receiving email from soldiers, airmen, marines and sailors because of a previous story I had written on the anthrax vaccine. ...

PharmAthene To Host Third Quarter 2009 Conference Call and Webcast on Thursday ...  -  ‎Nov 3, 2009‎
ReutersPharmAthene's lead product development programs include: -- SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third ...

RE: 2 Control Group proof  -  ‎Nov 12, 2009‎
OmniNerd (blog)The report recommended, “While an improved vaccine is being developed, use of the current anthrax vaccine for force protection against biological warfare ...

A better vaccine for anthrax  -  ‎Oct 30, 2009‎"The current anthrax vaccine, it takes too long. You need many immunizations to get the protection that is needed." Anthrax-laced letters killed five people ...

Squalene in H1N1 Vaccine  -  ‎Oct 27, 2009‎
Cryptome.org3) Does the anthrax vaccine use squalene as an adjuvant? 5) Should we be concerned about the presence of trace quantities of squalene in tetanus, ...

Business briefs  -  ‎Nov 7, 2009‎
Lansing State JournalThe company, which makes the only federally approved anthrax vaccine at a facility in Lansing that employs about 400, said it earned $949000, ...

Think more than twice before getting swine flu vaccine  -  ‎Nov 9, 2009‎
Sun Star CourierSqualene was added to the anthrax vaccine and given to our soldiers during the Gulf War. As a result, our soldiers developed Gulf War Syndrome. ...

PharmAthene Reports Third Quarter 2009 Financial and Operational Results  -  ‎Nov 12, 2009‎ (press release)..."New data from our Valortim® and third generation (3G) recombinant protective antigen (rPA) anthrax vaccine programs were presented at the Bacillus - ACT ...

O skwalenie w szczepionkach  -  ‎Nov 18, 2009‎
Salon 24...squalene concerns allegations that the The Gulf War Syndrome (GWS) is typified by high squalene antibodies in anthrax vaccine recipients [103134-137]. ...

Immunovaccine Expands Collaboration with Defence Research & Development Canada  -  ‎Nov 3, 2009‎ (press release)...its research agreement with Defence Research and Development Canada (DRDC) based on encouraging initial results achieved with the anthrax vaccine. ...

Separating myth from fact in debate about flu vaccine  -  ‎Oct 27, 2009‎
Vancouver SunFact: This stems from the discovery that some veterans who got the anthrax vaccine used by US soldiers during the 1991 Gulf War developed antibodies to ...

H1N1 Vaccine Deaths in Germany: German doctors issued warning about swine flu jab  -  ‎Nov 20, 2009‎
Center for Research on Globalization...injection and can provoke autoimmune diseases such as those found among US and UK soldiers who took squalene as part of the anthrax vaccine. ...

Think twice before getting vaccine  -  ‎Nov 5, 2009‎
BCLocalNews...used in virtually all of Canada's swine flu vaccines manufactured by Glaxo, and has been linked with the deadly anthrax vaccine used in the Gulf War. ...

BioWatch: Industry gears up for mid-Atlantic conference  -  ‎Oct 29, 2009‎
Business GazetteThe company manufactures BioThrax, the only anthrax vaccine approved by the Food and Drug Administration, and is developing a newer version that would ...

Two opposing views on H1N1 treatment  -  ‎Nov 12, 2009‎
Humboldt BeaconThese were noted when squalene was associated with the anthrax vaccine. Thimerosal is related to an increase in autism and Alzheimer's. ...

PharmAthene Inc (NYSE AMEX:PIP) to Release Q3 2009 Earnings  -  ‎Nov 6, 2009‎
TransWorldNews (press release)SparVax is a second generation rPA anthrax vaccine. Valortim is a fully human monoclonal antibody for the prevention and treatment of anthrax infection. ...

Drug merchants loot funds for the dying  -  ‎Nov 17, 2009‎
StandardThe ministry also bought 230000 doses of Anthrax vaccine, Blanthrax at Sh23 per dose although it normally retails at Sh7 per dose. ...

Swine Flu Spread Continues to Outpace Efforts to Treat and Prevent Disease  -  ‎Oct 30, 2009‎
Science Magazine (blog)This vaccine contains one million times the amount that was put in the experimental Anthrax vaccine that the Gulf War Vets got before going there. ...

Emergent BioSolutions Inc. Reports Operating Results (10-Q)  -  ‎Nov 6, 2009‎ Vaccine Adsorbed) is the only vaccine approved by the US Food and Drug Administration for the prevention of anthrax infection. ...

Federal Funding Finds Its Way to Biotech This Fall  -  ‎Nov 11, 2009‎
BioWorld OnlineMd., was awarded $4.9 million under an agreement with the NIAID, funded under the ARRA, for development of anthrax vaccine candidate dmPA7909. ...

News in Brief  -  ‎Nov 12, 2009‎
Ha'aretzAsenheim conducted the research that exposed the IDF's secret anthrax vaccine experiment on its soldiers. (Gili Izikovich) The Tel Aviv District Court ...

Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences  -  ‎Nov 2, 2009‎
ReutersEmergent`s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by the US Food and Drug Administration for the prevention of ...

Aluminum Hydroxide in Vaccines Linked to Neurological Damage  -  ‎Oct 29, 2009‎
American Chronicle..."Possible causes of GWS include several of the adjuvants in the anthrax vaccine and others. The most likely culprit appears to be aluminum hydroxide," says ...

RE: 2 Control Group proof  -  ‎Nov 11, 2009‎
OmniNerd (blog)The report details that testing fingerprint oil indicates off the charts squalene levels and that any squalene found in the anthrax vaccine was likely due ...

Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World ...  -  ‎Nov 4, 2009‎
Therapeutics Daily (press release) (registration)The Human Anthrax Vaccine Program must be stopped. Scott Miller and Company has completed the feature film "A Call to Arms:2009 Edition" and the one-hour ...

To be jabbed or not  -  ‎Oct 28, 2009‎
CBC.caSome people suggest the squalene in the adjuvant can be blamed for such conditions as Gulf War Syndrome (from anthrax vaccine) and Guillain-Barré Syndrome, ...

Your H1N1 vaccine questions answered  -  ‎Nov 2, 2009‎
Globe and MailFor example, it is claimed that the adjuvant used in the anthrax vaccine was to blame for Gulf War syndrome, but there was not adjuvant in that vaccine. ...

Vaxgen Inc. Q3 10Q Out; Greenbackd Exits, Dammit  -  ‎Nov 4, 2009‎ products� and rights to specified percentages of future net sales relating to its anthrax vaccine product candidate and related technology. ...

Mexicaanse griep: feiten en fabels  -  ‎Nov 10, 2009‎
NetwerkIn that study the investigators injected mice with adjuvants that mimicked the anthrax vaccine schedule set by the Anthrax Vaccine Immunization Program. ...

Aktuelle Daten zur Schweinegrippe  -  ‎Nov 11, 2009‎
ShortNews.deAntibodies to squalene in recipients of anthrax vaccine, Exp.Mol. Pathol. 2002 Aug; 73 (1): 19-27 ) Zudem ist in diesem Zusammenhang mehr als beunruhigend, ...

FDA approves shortened anthrax-vaccine course  -  Dec 22, 2008
CIDRAP,...(FDA) recently approved a new version of BioThrax—the nation's only licensed anthrax vaccine—that requires fewer doses and changes the injection route.

Vaxin wins grant to continue tests for anthrax vaccine  -  Dec 10, 2008,Vaxin Inc. has received a $1.4 million federal research grant to further develop an anthrax vaccine. The Birmingham-based vaccine development firm won a

FDA approves new version of Emergent vaccine  -  Dec 19, 2008
MSNBCROCKVILLE, Md. - Biotechnology company Emergent BioSolutions Inc. said Friday US health regulators approved a new version of its anthrax vaccine that

US Extends Anthrax Vaccine Funding for Alabama Firm  -  Dec 11, 2008
Global Security Newswire,The US National Institutes of Health has provided an Alabama biotechnology firm with $1.4 million in new funding to pursue a next-generation anthrax vaccine

Snafus Mar Vaccine Program  -  Dec 4, 2008
ProPublica,...“I think the assertion is correct that the federal sector did not fully understand what it would take� to develop a new anthrax vaccine, Vanderwagen said.

Sudden Death In Adult Cattle  -  Dec 11, 2008,The cattle will also be vaccinated with the anthrax vaccine. The CDFA and your county health officials will advise regarding the proper disposal of the dead

Business digest  -  Dec 20, 2008
Lansing State Journal,Scientists began looking at injecting the anthrax vaccine in that manner to reduce side effects, including swelling and redness.

Emergent wins US approval for new BioThrax formulation  -  Dec 22, 2008
SmartBrief,The company has a supply contract for the anthrax vaccine with the US government, which is working to stockpile more than 14 million doses into 2011.

Emergent Biosolutions spent $575K lobbying in 3Q  -  Dec 8, 2008
Forbes,...(nyse: EBS - news - people ) holds a three-year, $448 million contract with the Department of Health and Human Services for the anthrax vaccine BioThrax.

Other News To Note  -  Dec 19, 2008
TMCnetEmergent BioSolutions Inc., of Rockville, Md., said the FDA approved its supplemental biologics license application for anthrax vaccine BioThrax,

Anthrax and bio-terrorism  -  Dec 5, 2008
News Today Online,The human anthrax vaccine boosts the immune system and 93% effective, but it is not available for use by the general public. Immunization is not immediate.

Five Hot Stocks For The Long Run  -  Dec 5, 2008
Forbes,That's a great sign and probably has a lot to do with the success of its anthrax vaccine. PetMed Express (nasdaq: PETS - news - people ) While consumers

Not Mental, Says Official Study  -  Dec 2, 2008
American Free Press,In an overhead presentation at the release, DU’s demotion was clearly evident; it was listed along with anthrax vaccine, fuel and solvents under the

40 Top Rated Emerging Bio-Pharma Stocks  -  Dec 23, 2008
Seeking Alpha,Emergent BioSolutions (EBS) continued its amazing run with an additional 45% gain in the past month on a sBLA approval for BioThrax (anthrax vaccine),

Gulf War veterans deserve VA help  -  Dec 16, 2008
Clarksville Leaf Chronicle,The report does conclude there is no clear link between GWI and a veteran's exposure to substances such as depleted uranium or an anthrax vaccine

Seeking Stock With Over 40% Insider Ownership (CPB, EBS)  -  Dec 22, 2008
Investopedia,This license is for an anthrax vaccine (BioThrax), and will reduce the total number of vaccinations from six (under the skin) to five (into the muscle).

Only 3 portfolios in black with month left  -  Dec 5, 2008
Toledo Blade,The stock of the firm that makes an anthrax vaccine has gained 342 percent through Dec. 1 this year. But both men's other three stocks have sustained

Emergent BioSolutions, Inc. (EBS)  -  Dec 5, 2008,The company said its solid showing was driven by sales of its anthrax vaccine BioThrax, which climbed 55% from last year to $55.5 million.

Bailouts: a threat to national security  -  Dec 12, 2008
American Chronicle,Mark has helped raise awareness of military and veterans' issues, by establishing No Anthrax Vaccine. His commentary has been carried by such sites as

Send Ben Bernanke to the asylum  -  Dec 4, 2008
American Chronicle,Mark has helped raise awareness of military and veterans' issues, by establishing No Anthrax Vaccine. His commentary has been carried by such sites as

Background information on Anthrax Vaccine [When available]

Anthrax is an infectious disease caused by spores of the bacterium, Bacillus anthracis. The B. anthracis spores are highly resistant to inactivation and may be present in the soil, for example, for decades, occasionally infecting grazing animals that ingest the spores. Goats, sheep and cattle are examples of animals that may become infected. Human infection may occur by three routes of exposure to anthrax spores: cutaneous (through the skin), gastrointestinal (by ingestion), and pulmonary (inhalation). In North America, human cases of anthrax are infrequent. However, the United States military views anthrax as a potential biological terrorism threat because the spores are so resistant to destruction and can be easily spread by release in the air. The development of anthrax as a biological weapon by several foreign countries has been documented.

Human anthrax cases can occur in 3 forms. Cutaneous infection is the most common manifestation of anthrax in humans, accounting for more than 95 percent of cases. Ingestion of undercooked or raw, infected meat can cause gastrointestinal anthrax infection. Breathing in airborne spores may lead to inhalation anthrax. The mortality rates from anthrax vary, depending on exposure, and are approximately 20% for cutaneous anthrax without antibiotics and 25 - 75% for gastrointestinal anthrax; inhalation anthrax has a fatality rate that is 80% or higher. Cutaneous anthrax can usually be successfully treated with antibiotics and some antibiotics have also been approved for post-exposure prophylaxis.

The only known effective pre-exposure prevention against anthrax is the anthrax vaccine. The vaccine was developed from an attenuated strain of B. anthracis. The vaccine derives from the cell-free culture filtrate of this strain and, in its final formulation, is adsorbed onto an aluminum salt. A well controlled clinical trial using an anthrax vaccine similar to the licensed anthrax vaccine was conducted in U.S. mill workers processing imported animal hair. During the trial, 26 cases of anthrax were reported at the mills - five inhalation and 21 cutaneous cases. Of the five inhalation cases, two individuals had received the placebo, while three individuals were in the observational group. Four of the five people who developed inhalation anthrax died. No cases of inhalation anthrax occurred in anthrax vaccine recipients. Based upon a comparison between the anthrax vaccine and placebo recipients, the authors calculated a vaccine efficacy level of 92.5 percent.

The licensed anthrax vaccine, termed Anthrax Vaccine Adsorbed (or AVA) is recommended for individuals who may come in contact with animal products that may be contaminated with Bacillus anthracis spores and for individuals engaged in diagnostic or investigational activities which may bring them in contact with Bacillus anthracis spores. It is also recommended for persons at high risk, such as veterinarians and others handling potentially infected animals. There is only a single anthrax vaccine licensed in the U.S.; the vaccine is manufactured by BioPort Corporation, located in Lansing, Michigan (Anthrax Vaccine Adsorbed (Biothrax) package insert). New vaccines using current technology are under development.

Because of biological warfare threats, the military has had an active vaccination program against anthrax.

source: USFDA

Search the web for more resources on Anthrax Vaccine

Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

The Cancer News Network


Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on lead to other sites. does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is responsible for dead or misdirected links.

We will do our best to accommodate your request.